Ï㽶ÊÓƵ

Larry C. Lands

Academic title(s): 

ProfessorÌý

MD, PhDÌý

Larry C. Lands
Contact Information
Address: 

Director, Pediatric Respiratory Medicine
Montreal Children’s Hospital
1001 Decarie Boulevard, BRC 7016
Montreal, Quebec, H4A 3J1

Email address: 
larry.lands [at] mcgill.ca
Division: 
Respiratory Medicine
Area(s): 
Clinical trials
Patient centered outcomes
Patient-oriented research
Degree(s): 
  • MDCM, Ï㽶ÊÓƵ, 1981Ìý
  • Pediatrics, Montreal Children’s Hospital, 1984Ìý
  • Pediatric Respiratory Medicine, Montreal Children’s Hospital, 1986Ìý
  • PhD, Medical Sciences, McMaster University, 1993
Biography: 

Dr. Larry Lands’ clinical research focuses on improving the functional capacity of those living with chronic conditions such as Cystic Fibrosis (CF) and obesity.Ìý

Our goal is to improve the functional ability of those living with conditions that impair their breathing capacity. We are developing oscillometry as a simple non-invasive test to assess lung function across the lifespan. We are studying why some adolescents living with obesity have exercise limitation so that we can improve their level of fitness. Our laboratory-based research is focused on improving the function of the epithelial cells lining the airways in chronic lung disease including Cystic Fibrosis (CF), Primary Ciliary Dyskinesia (PCD), asthma, and Chronic Obstructive Pulmonary Disease. We are developing novel inhaled lipid nanoparticles to deliver antisense oligonucleotide and mÏ㽶ÊÓƵ constructs to correct the genetic mutations that cause CF and PCD, reduce inflammation in asthma, and rejuvenate the respiratory epithelium in Chronic Obstructive Pulmonary Disease. As a member of the Department of Pediatrics, Dr. Lands shared that he gains from “the multidisciplinary and interdisciplinary clinical and scientific capacities across the Departmentâ€.

Areas of expertise: 
  • Respiratory physiologyÌý
  • Exercise physiologyÌý
  • Lipid nanoparticlesÌý
  • Respiratory epithelial cellular molecular biologyÌý
Areas of interest: 
  • Oscillometry across the lifespanÌý
  • Exercise capacity in chronic conditionsÌý
  • Inhaled Ï㽶ÊÓƵ therapeuticsÌýÌý
  • Cystic FibrosisÌý
  • Primary Ciliary DyskinesiaÌý
  • Chronic Obstructive Pulmonary DiseaseÌý
  • ObesityÌý
  • Mucolytic therapiesÌý
Awards, honours, and fellowships: 
  • Chair of the Research Committee of the Canadian Thoracic SocietyÌýÌý
  • Chair of Cystic Fibrosis Canada’s Research Advisory CouncilÌý
Back to top